Page 237 - Immunization Practices News Today

We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global community, the FDAs Peter Marks said.

Taipei, May 5 (CNA) The phase 3 clinical trial of a vaccine for the enterovirus 71 (EV71) virus which is safe for babies as young as two months has been successful, a research team announced on Thursday, expecting it to hit the market in early 2023.

The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).

/PRNewswire/ -- Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and...

/PRNewswire/ -- Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and...

At the heart of the debate over Twitter’s model for content moderation lies a deeper question: Is it possible to engender greater trust in online information and discourse?

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Brigham's Dr. Daniel Kuritzkes examines why millions of older Americans are hesitating to get a second booster shot for COVID-19.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

With high levels of tree pollen now in the air and highly-contagious COVID variants spreading this spring, it can be increasingly difficult to identify the...